The performance of Qisda’s revenue and profit for the first half was remarkable, with transformation the layout of the High Value-Added Business and the Information Technology Business both delivering outstanding results. Coupled with the continued positive contributions from outside the industry that drove Qisda’s consolidated revenue growth of 29%, operating margin growth of 47%, and net income attributable to the parent company of 401%. The gross margin, operating margin, and net profit margin have all increased, with EPS of NTD3.01. Not only were these results new highs in 10 years, but they also surpassed the all-year level of the past decade.

An online Qisda investor conference was held on the 12th to further explain the operating results for the 2nd quarter and future outlook.

According to Chairman Peter Chen: “Qisda is striving for achieving the goal of earning more than half of its revenue from the High Value-Added Business, while at the same time improving profitability to bring positive contributions. Looking ahead to the 3rd quarter, Qisda is optimistic about the growth of revenue and profitability in the High Value-Added Business. Within the business, the Medical Business has maintained a high level of growth, while the Smart Solutions Business layout will be deepened and expanded. With the pandemic outbreak and the supply chain still posing challenges, changes in the overall environment must be dealt with in a stringent manner.”

The consolidated revenue of Qisda for the first half totaled NTD106.9 billion; net operating profit totaled NTD3.6 billion; net income attributable to the parent company totaled NTD5.9 billion, representing growth of 29%, 47% and 401%, respectively, from the same period last year, with the EPS of NTD3.01 for the first half. The operating performance was remarkable, with a gross profit margin of 14.7%, up 1.2 percentage points; operating margin of 3.4%, up 0.4 percentage points; and a net profit margin of 6.5%, up 4.6 percentage points.

Qisda’s revenue for the 2nd quarter continues to grow by double digits, with consolidated revenue of NTD56 billion, up 28% from the same period last year; operating margin totaled NTD1.9 billion, up 33% from the same period last year; and net income attributable to the parent company totaled NTD3.8 billion, up 301% from the same period last year. With these three items hitting a 10-year single-quarter high, the 2nd quarter of EPS also reached NTD1.93.

In addition, starting from the 2nd quarter, the investment in AUO will be recognized as “fair value through other comprehensive income or loss (FVOCI)” from the “equity method,” affecting a total of NTD2.4 billion, a positive contribution to non-operating earnings in the 2nd quarter.

With Qisda’s dedication to optimizing the performance of each business, while enhancing the contribution of new value transformation business, the revenue from High Value-Added Business for the 2nd quarter grew by 94% from the same period last year, accounting for more than 30% of revenue for 4 quarters in a row. The Medical Business maintained a high level of growth, a 42% increase from the same period last year. It will remain as one of the factors that drives growth in the 3rd quarter with healthy medical center operations and expanded pandemic prevention supplies.

Summary of Qisda’s consolidated financial statements for 2021 Q2:

Turnover totaled NTD55.984 billion, up NTD12.311 billion from the same period last year, an annual increase of 28%

Operating margin totaled NTD1,907 million, an increase of NTD472 million, an annual increase of 33%

Gross margin was 14.8%, an annual increase of 1.2 percentage points

Operating margin was 3.4%, an annual increase of 0.1 percentage points

Net operating profit after tax totaled NTD4,388 million, up NTD3,175 million from the same period last year, an annual increase of 262%

Net income attributable to the parent company totaled NTD3,805 million, up NTD2,857 million from the same period last year, an annual increase of 301%

Basic earnings per share was NTD1.93